Daily briefing: The future of psychedelics
Nature · 27.10.2026
DOI: 10.1038/d41586-026-03482-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nature, online erschienen am 27.10.2026. Verfasst von Jacob Smith.
Abstract (Originalsprache)
Despite setbacks, pharma companies are betting big on psychedelic drugs to treat mental-health conditions. Plus, longevity researchers are turning their attention to pets and how to keep tabs on the tools in your lab. Despite setbacks, pharma companies are betting big on psychedelic drugs to treat mental-health conditions. Plus, longevity researchers are turning their attention to pets and how to keep tabs on the tools in your lab.
Zitieren
APA
Smith, J. (2026). Daily briefing: The future of psychedelics. Nature. https://doi.org/10.1038/d41586-026-03482-5
Vancouver
Smith J. Daily briefing: The future of psychedelics. Nature. 2026. doi:10.1038/d41586-026-03482-5
BibTeX
@article{Smith2026,
author = {Smith, Jacob},
title = {Daily briefing: The future of psychedelics},
journal = {Nature},
year = {2026},
doi = {10.1038/d41586-026-03482-5}
}
EUVIMED